Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma
Cancer
.
2019 Apr 15;125(8):1384-1385.
doi: 10.1002/cncr.31961.
Epub 2019 Feb 1.
Author
Remington L Nevin
1
Affiliation
1
The Quinism Foundation, White River Junction, Vermont.
PMID:
30707755
DOI:
10.1002/cncr.31961
No abstract available
Publication types
Letter
Comment
MeSH terms
Glioblastoma*
Humans
Mefloquine
Memantine
Metformin*
Temozolomide
Substances
Metformin
Mefloquine
Memantine
Temozolomide